is tirzepatide a biologic | C225H348N48O68 | CID 156588324 Tirzepatide | GLP-1R and GIPR

Clinical trials have demonstrated that Tirzepatide can lead to an average weight loss of up to 22.5% of body weight, surpassing many previous weight loss medications

On the downside, there can be some pretty severe side effects all sorts of gastro problems that I still experience, general feelings of unwellness mainly the day after injections

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide activates only the GLP-1 receptor and tirzepatide activates GLP-1 and GIP receptors

This reflects a broader access problem that disproportionately affects lupus patients because their indication for these medications (managing corticosteroid-induced weight gain and reducing cardiovascular risk in an autoimmune condition) does not fit neatly into approved indication categories

Structurally identical to the biologically active 129 N-terminal amino acids of native GHRH, Sermorelin preserves full receptor agonist activity

Together, they create a metabolic environment where fat oxidation occurs efficiently and appetite stays suppressed without willpower